• Login
• Admin

Bath, Philip M.W., Woodhouse, Lisa J., Appleton, Jason P., Beridze, M., Christensen, Hanne, Dineen, Robert A., Duley, Lelia, England, Timothy J., Flaherty, Katie, Havard, Diane, Heptinstall, Stan, James, Marilyn, Krishnan, Kailash, Markus, H.S., Montgomery, Alan A., Pocock, Stuart J., Randall, Marc, Ranta, A., Robinson, Thompson G., Scutt, Polly, Venables, Graham S. and Sprigg, Nikola (2018) Antiplatelet therapy with aspirin, clopidogrel, and dipyridamole versus clopidogrel alone or aspirin and dipyridamole in patients with acute cerebral ischaemia (TARDIS): a randomised, open-label, phase 3 superiority trial. Lancet, 391 (10123). pp. 850-859. ISSN 1474-547X

Bath, Philip M.W., Appleton, Jason P., Beridze, M., Christensen, Hanne, Dineen, Robert A., Duley, Lelia, England, Timothy J., Heptinstall, Stan, James, Marilyn, Krishnan, Kailash, Markus, H.S., Pocock, Stuart J., Ranta, A., Robinson, Thompson G., Flaherty, Katie, Scutt, Polly, Venables, G., Woodhouse, Lisa J. and Sprigg, Nikola (2017) Baseline characteristics of the 3,096 patients recruited into the 'Triple Antiplatelets for Reducing Dependency after Ischaemic Stroke' (TARDIS) trial. International Journal of Stroke, 12 (5). pp. 524-538. ISSN 1747-4949

Beridze, M., Christensen, H., Dineen, Robert A., Duley, Lelia, Heptinstall, Stan, James, M., Markus, H.S., Pocock, S, Ranta, A., Robinson, T., Nikola, N., Venables, G. and Bath, Philip M.W. (2015) Safety and efficacy of intensive vs. guideline antiplatelet therapy in high-risk patients with recent ischemic stroke or transient ischemic attack: rationale and design of the Triple Antiplatelets for Reducing Dependency after Ischaemic Stroke (TARDIS) trial (ISRCTN47823388). International Journal of Stroke, 10 (7). pp. 1159-1165. ISSN 1747-4949